Yanira Ruiz‐Heredia

Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma

Joaquín Martínez‐López, Beatriz Sánchez-Vega, Santiago Barrio et al. · Leukemia · 2017 · 51 citations · Full text

Life Sciences, Molecular Biology, Oncology +8

A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia

Esther Onecha, María Linares, Inmaculada Rapado et al. · Haematologica · 2018 · 51 citations · Full text

Medicine, Hematology, Oncology +17

Cereblon enhancer methylation and IMiD resistance in multiple myeloma

Larissa Haertle, Santiago Barrio, Umair Munawar et al. · Blood · 2021 · 46 citations · Full text

Medicine, Cancer Biology, Oncology +16

Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT

Ana Jiménez Ubieto, María Poza, Alejandro Martín-Muñoz et al. · Leukemia · 2023 · 38 citations · Full text

Medicine, Clinical Sciences, Oncology +16

A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics

Ricardo Sánchez, Jordi Ribera, Mireia Morgades et al. · Blood Cancer Journal · 2020 · 22 citations · Full text

Medicine, Hematology, Oncology +16